Korean J Pathol.
2000 Jan;34(1):34-38.
Expression of Cytokeratin 7 and 20 in Periampullary Carcinomas
- Affiliations
-
- 1Department of Diagnostic Pathology, Samsung Medical Center Sungkyunkwan
University School of Medicine, Seoul 135-710, Korea.
Abstract
-
The distinction of carcinomas involving periampullary region is often difficult, even in
the surgically resected specimens. To examine the differences in the expressions of
cytokeratin (CK) 7 and 20 in the periampullary carcinomas, we performed
immunohistochemical studies on surgically resected 20 pancreatic duct adenocarcinomas
(PDA), 13 distal bile duct adenocarcinomas (DBA), 10 duodenal adenocarcinomas (DA), and
18 ampulla of Vater adenocarcinomas (AVA). We analyzed the relationships between CK
7/CK 20 immunoprofile, and tumor cell differentiation and tumor size. We interpreted diffuse
cytoplasmic reactivity found in > or =5% of tumor cells as positive. In the majority of cases,
PDA were CK 7 /20 (95%), DBA CK 7 /20 (92.3%), DA either CK 7 /20 (40%) or
CK 7 /20 (30%), AVA either CK 7 /20 (50%) or CK 7 /20 (44.4%). In DA, there
was an increased CK 20 negativity in less differentiated (moderately or poorly differentiated)
cases (p<0.05) and in larger (> or =5 cm) tumor size (p=0.049). In AVA, there was a tendency
of increased CK 20 positivity in less differentiated cases (p=0.10). In conclusion, the CK 7/CK
20 immunophenotype is useful in the differentiation of periampullary carcinomas: the CK 7
/CK 20 immunophenotype strongly suggests DA or AVA, whereas the CK 7 /CK 20
immunophenotype suggests PDA or DBA.